rs796053480
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PM4_SupportingBP6BS2
The NM_000548.5(TSC2):c.5394_5396delCTC(p.Ser1799del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000087 in 1,608,830 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S1798S) has been classified as Likely benign.
Frequency
Consequence
NM_000548.5 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant polycystic kidney diseaseInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- polycystic kidney disease 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- autosomal recessive polycystic kidney diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Caroli diseaseInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TSC2 | ENST00000219476.9 | c.5394_5396delCTC | p.Ser1799del | disruptive_inframe_deletion | Exon 42 of 42 | 5 | NM_000548.5 | ENSP00000219476.3 | ||
| PKD1 | ENST00000262304.9 | c.*1148_*1150delGAG | downstream_gene_variant | 1 | NM_001009944.3 | ENSP00000262304.4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152154Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000122 AC: 3AN: 245802 AF XY: 0.00000747 show subpopulations
GnomAD4 exome AF: 0.00000824 AC: 12AN: 1456676Hom.: 0 AF XY: 0.00000552 AC XY: 4AN XY: 724872 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152154Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74322 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Tuberous sclerosis syndrome Uncertain:1
The TSC2 c.5394_5396del (p.Ser1799del) change has a maximum subpopulation frequency of 0.0041% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/variant/16-2138577-TCTC-T). The change results in the deletion of a single serine residue in a region without a known function at the c-terminal end of the gene (BP3). To our knowledge, functional studies have not been performed. This variant has been reported in a woman with lymphangioleiomyomatosis (PMID: 31856217). In summary, this variant meets criteria to be classified as of uncertain significance based on the ACMG/AMP criteria: BP3. -
not provided Uncertain:1
In-frame deletion of 1 amino acid in a non-repeat region; Previously reported as a variant of uncertain significance in a woman with a clinical diagnosis of tuberous sclerosis and lymphangioleiomyomatosis (Liu et al., 2019); In silico analysis supports a deleterious effect on protein structure/function; Published functional studies demonstrate reduced levels of TSC1 and TSC2 protein and elevated levels of phosphorylated AKT (Mrozek et al., 2021); This variant is associated with the following publications: (PMID: 31856217, 33891611) -
Hereditary cancer-predisposing syndrome Uncertain:1
The c.5394_5396delCTC variant (also known as p.S1799del) is located in coding exon 41 of the TSC2 gene. This variant results from an in-frame CTC deletion at nucleotide positions 5394 to 5396. This results in the in-frame deletion of a serine at codon 1799. This alteration has been reported as a germline variant of unknown significance in an individual with lymphangioleiomyomatosis (LAM) (Liu J et al. PLoS One, 2019 Dec;14:e0226400). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Tuberous sclerosis 2 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at